Injectables Specials through June 30

Some injectable / facial filler specials continue through the end of June. Please call the office for specific details and requirements for the special pricing and/or rebates. Save up to $390 on Restylane or Perlane through June 30 (with below savings, up to 6 ml per visit).

• $50 off each (ml) of Restylane or RestylaneL used in your treatment (minimum of 2 ml required).
• $65 off each ml of Perlane or PerlaneL used in your treatment (minimum purchase of 1 ml required).
• Also the $50 rebate on Dysport continues until June 30, 2011. 

All specials expire June 30, 2011. Please call the office for more information at 781-934-2200.

Dysport™ Is Here: Competitor to Botox® Now Available

I'm pleased to announce that I am now offering Dysport™ from Medicis (makers of Restylane and Perlane), which is a "botulinum toxin" similar to Botox®. Dysport has been approved by the FDA for the aesthetic indication (glabellar lines) — for the temporary improvement in the appearance of moderate to severe glabellar lines in adults younger than 65 years of age. The active substance in Dysport is a botulinum neurotoxin type A complex. Now I can discuss more options with my patients for treatment of wrinkles and frown lines.

Stay tuned for more information on this new injectable. In the meantime, please see the press release: Medicis Begins Shipping Dysport(TM) for Glabellar Lines.

See related post: Enter Dysport: Here Come the Botox Competitors.

Dr. Hamori Speaks on Latest Cosmetic Trends

As you may know, Dr. Hamori is committed to staying up-to-date with the latest technologies and surgical procedures and cosmetic treatments, and is active not only attending professional conferences but also speaking and presenting to her peers on the latest cosmetic treatments and trends. For instance, at the ASAPS Annual Convention in Las Vegas last month, Dr. Hamori spoke on the "Hot Topics" panel and was interviewed on the Plastic Surgery Channel regarding the trend in Labiaplasty, also now being called Cosmetic GYN.


Click here to view video.

Enter Dysport: Here Come the Botox Competitors
Next month, Dr. Hamori will speak about Dysport, from Medicis (an up and coming Botox competitor) and its family of injectables (Restylane/Perlane) with other physicians during the American Association of Dermatologists meeting in Boston. Dr. Hamori expects to have the new product in the office to inject very soon.

Here is a link to yesterday's news release on Dysport (formerly known as Reloxin) becoming available in the U.S.: Medicis Begins Shipping Dysport(TM) for Glabellar Lines.

And here is the WebMD report on Dysport's FDA approval.
Stay tuned for more news on Dysport.